Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3730-3739

  Ouwendijk, Werner J D ^a   Geluk, Annemieke ^b   Smits, Saskia L ^a   Getu, Sarah ^a   Osterhaus, Albert D M E ^a   Verjans, Georges M G M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CELL LINE; CONSERVED SEQUENCE; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 3, HUMAN; HLA-DR ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL; SEQUENCE ALIGNMENT; TRANS-ACTIVATORS; UVEITIS; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 84898656266     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302307     Document Type: Article

References (75)

1. Roizman, B., D. M. Knipe, and R. J. Whitley. 2007. Herpes simplex viruses. In Fields Virology, 5th Ed., D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkens, Philadelphia, PA, p. 2501-2601.
2. Cohen, J. I., S. E. Straus, and A. M. Arvin. 2007. Varicella-zoster virus replication, pathogenesis, and management. In Fields Virology, 5th Ed., D. M. Knipe, and P. M. Howley, eds. Lippincott Williams and Wilkins, Philadelphia, PA, p. 2773-2818.
3. Arvin, A. M., C. M. Koropchak, B. R. Williams, F. C. Grumet, and S. K. Foung. 1986. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J. Infect. Dis. 154: 422-429.
4. Khanna, K. M., R. H. Bonneau, P. R. Kinchington, and R. L. Hendricks. 2003. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18: 593-603.
5. Miller, A. E. 1980. Selective decline in cellular immune response to varicellazoster in the elderly. Neurology 30: 582-587.
6. Nash, A. A., A. Jayasuriya, J. Phelan, S. P. Cobbold, H. Waldmann, and T. Prospero. 1987. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68: 825-833.
7. Verjans, G. M. G. M., and A. Heiligenhaus. 2011. Herpes simplex virus-induced ocular diseases: detrimental interaction between virus and host. Curr. Immunol. Rev. 7: 310-327.
8. Hillenkamp, J., B. Nolle, C. Bruns, P. Rautenberg, H. Fickenscher, and J. Roider. 2009. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes. Ophthalmology 116: 1971-1975 e1972.
9. Ritterband, D. C., and D. N. Friedberg. 1998. Virus infections of the eye. Rev. Med. Virol. 8: 187-201.
10. Zamir, E. 2005. Herpetic posterior uveitis. Int. Ophthalmol. Clin. 45: 89-97.
11. Azumi, A., and S. S. Atherton. 1998. T cells in the uninjected eye after anterior chamber inoculation of herpes simplex virus type 1. Invest. Ophthalmol. Vis. Sci. 39: 78-83.
12. Cousins, S. W., A. Gonzalez, and S. S. Atherton. 1989. Herpes simplex retinitis in the mouse. Clinicopathologic correlations. Invest. Ophthalmol. Vis. Sci. 30: 1485-1494.
13. Deschenes, J., W. R. Freeman, D. H. Char, and M. R. Garovoy. 1986. Lymphocyte subpopulations in uveitis. Arch. Ophthalmol. 104: 233-236.
14. Matsuo, T., T. Nakayama, T. Koyama, and N. Matsuo. 1987. Cytological and immunological study of the aqueous humor in acute retinal necrosis syndrome. Ophthalmologica 195: 38-44.
15. Pettit, T. H., S. J. Kimura, Y. Uchida, and H. Peters. 1965. Herpes simplex uveitis: an experimental study with the fluorescein-labeled antibody technique. Invest. Ophthalmol. 4: 349-357.
16. Whittum-Hudson, J., M. Farazdaghi, and R. A. Prendergast. 1985. A role for T lymphocytes in preventing experimental herpes simplex virus type 1-induced retinitis. Invest. Ophthalmol. Vis. Sci. 26: 1524-1532.
17. Milikan, J. C., G. S. Baarsma, R. W. Kuijpers, A. D. Osterhaus, and G. M. Verjans. 2009. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 50: 743-751.
18. Milikan, J. C., P. R. Kinchington, G. S. Baarsma, R. W. Kuijpers, A. D. Osterhaus, and G. M. Verjans. 2007. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virusinduced uveitis. Invest. Ophthalmol. Vis. Sci. 48: 3689-3697.
19. Milikan, J. C., R. W. Kuijpers, G. S. Baarsma, A. D. Osterhaus, and G. M. Verjans. 2006. Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis. Exp. Eye Res. 83: 69-75.
20. Verjans, G. M., M. E. Dings, J. McLauchlan, A. van Der Kooi, P. Hoogerhout, H. F. Brugghe, H. A. Timmermans, G. S. Baarsma, and A. D. Osterhaus. 2000. Intraocular T cells of patients with herpes simplex virus (HSV)-induced acute retinal necrosis recognize HSV tegument proteins VP11/12 and VP13/14. J. Infect. Dis. 182: 923-927.
21. Verjans, G. M., E. J. Feron, M. E. Dings, J. G. Cornelissen, A. Van der Lelij, G. S. Baarsma, and A. D. Osterhaus. 1998. T cells specific for the triggering virus infiltrate the eye in patients with herpes simplex virus-mediated acute retinal necrosis. J. Infect. Dis. 178: 27-34.
22. Culbertson, W. W., M. S. Blumenkranz, H. Haines, D. M. Gass, K. B. Mitchell, and E. W. Norton. 1982. The acute retinal necrosis syndrome. Part 2: Histopathology and etiology. Ophthalmology 89: 1317-1325.
23. Culbertson, W. W., M. S. Blumenkranz, J. S. Pepose, J. A. Stewart, and V. T. Curtin. 1986. Varicella zoster virus is a cause of the acute retinal necrosis syndrome. Ophthalmology 93: 559-569.
24. Kuppermann, B. D., J. I. Quiceno, C. Wiley, J. Hesselink, R. Hamilton, K. Keefe, R. Garcia, and W. R. Freeman. 1994. Clinical and histopathologic study of varicella zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am. J. Ophthalmol. 118: 589-600.
25. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicellazoster virus. J. Gen. Virol. 67: 1759-1816.
26. Cohen, J. I., D. Heffel, and K. Seidel. 1993. The transcriptional activation domain of varicella-zoster virus open reading frame 62 protein is not conserved with its herpes simplex virus homolog. J. Virol. 67: 4246-4251.
27. Kinchington, P. R., K. Fite, and S. E. Turse. 2000. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 74: 2265-2277.
28. Felser, J. M., P. R. Kinchington, G. Inchauspe, S. E. Straus, and J. M. Ostrove. 1988. Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. J. Virol. 62: 2076-2082.
29. Jing, L., J. Haas, T. M. Chong, J. J. Bruckner, G. C. Dann, L. Dong, J. O. Marshak, C. L. McClurkan, T. N. Yamamoto, S. M. Bailer, et al. 2012. Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J. Clin. Invest. 122: 654-673.
30. Eisfeld, A. J., M. B. Yee, A. Erazo, A. Abendroth, and P. R. Kinchington. 2007. Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinasedependent and-independent mechanisms. J. Virol. 81: 9034-9049.
31. La Boissiere, S., A. Izeta, S. Malcomber, and P. O'Hare. 2004. Compartmentalization of VP16 in cells infected with recombinant herpes simplex virus expressing VP16-green fluorescent protein fusion proteins. J. Virol. 78: 8002-8014.
32. Verjans, G. M., R. Q. Hintzen, J. M. van Dun, A. Poot, J. C. Milikan, J. D. Laman, A. W. Langerak, P. R. Kinchington, and A. D. Osterhaus. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. USA 104: 3496-3501.
33. Langerak, A. W., P. J. Groenen, M. Bruggemann, K. Beldjord, C. Bellan, L. Bonello, E. Boone, G. I. Carter, M. Catherwood, F. Davi, et al. 2012. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia 26: 2159-2171.
34. Singh, H., and G. P. Raghava. 2001. ProPred: prediction of HLA-DR binding sites. Bioinformatics 17: 1236-1237.
35. Bui, H. H., J. Sidney, B. Peters, M. Sathiamurthy, A. Sinichi, K. A. Purton, B. R. Mothe, F. V. Chisari, D. I. Watkins, and A. Sette. 2005. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics 57: 304-314.
36. Guan, P., C. K. Hattotuwagama, I. A. Doytchinova, and D. R. Flower. 2006. MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl. Bioinformatics 5: 55-61.
37. Nielsen, M., C. Lundegaard, and O. Lund. 2007. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8: 238.
38. Wan, J., W. Liu, Q. Xu, Y. Ren, D. R. Flower, and T. Li. 2006. SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics 7: 463.
39. Geluk, A., V. Taneja, K. E. van Meijgaarden, E. Zanelli, C. Abou-Zeid, J. E. Thole, R. R. de Vries, C. S. David, and T. H. Ottenhoff. 1998. Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice. Proc. Natl. Acad. Sci. USA 95: 10797-10802.
40. Tyler, J. K., and R. D. Everett. 1994. The DNA binding domains of the varicellazoster virus gene 62 and herpes simplex virus type 1 ICP4 transactivator proteins heterodimerize and bind to DNA. Nucleic Acids Res. 22: 711-721.
41. Lefranc, M. P. 2001. Nomenclature of the human T cell receptor genes. Curr. Protoc. Immunol. Appendix 1: 1O.
42. Neefjes, J., M. L. Jongsma, P. Paul, and O. Bakke. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11: 823-836.
43. Painter, C. A., and L. J. Stern. 2012. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications. Immunol. Rev. 250: 144-157.
44. Greenbaum, J., J. Sidney, J. Chung, C. Brander, B. Peters, and A. Sette. 2011. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a suprising degree of repertoire sharing across supertypes. Immunogenetics 63: 325-335.
45. Schneider, S. C., J. Ohmen, L. Fosdick, B. Gladstone, J. Guo, A. Ametani, E. E. Sercarz, and H. Deng. 2000. Cutting edge: introduction of an endopeptidase cleavage motif into a determinant flanking region of hen egg lysozyme results in enhanced T cell determinant display. J. Immunol. 165: 20-23.
46. Sercarz, E. E., P. V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11: 729-766.
47. Shastri, N., A. Miller, and E. E. Sercarz. 1986. Amino acid residues distinct from the determinant region can profoundly affect activation of T cell clones by related antigens. J. Immunol. 136: 371-376.
48. Chan, C. C., B. Detrick, R. B. Nussenblatt, A. G. Palestine, L. S. Fujikawa, and J. J. Hooks. 1986. HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch. Ophthalmol. 104: 725-729.
49. Liversidge, J. M., H. F. Sewell, and J. V. Forrester. 1988. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-γ. Clin. Exp. Immunol. 73: 489-494.
50. Percopo, C. M., J. J. Hooks, T. Shinohara, R. Caspi, and B. Detrick. 1990. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J. Immunol. 145: 4101-4107.
51. Barry, M., and R. C. Bleackley. 2002. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2: 401-409.
52. Kalantari-Dehaghi, M., S. Chun, A. A. Chentoufi, J. Pablo, L. Liang, G. Dasgupta, D. M. Molina, A. Jasinskas, R. Nakajima-Sasaki, J. Felgner, et al. 2012. Discovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling. J. Virol. 86: 4328-4339.
53. Kuhn, J. E., K. Klaffke, K. Munk, and R. W. Braun. 1990. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch. Virol. 112: 203-213.
54. Wolff, M. H., F. Buchel, and A. Zoll. 1979. Serological studies on the antigenic relationship between herpes simplex virus and varicella-zoster virus. Immunobiology 156: 76-82.
55. Johnston, C., D. M. Koelle, and A. Wald. 2011. HSV-2: in pursuit of a vaccine. J. Clin. Invest. 121: 4600-4609.
56. Ouwendijk, W. J., K. J. Laing, G. M. Verjans, and D. M. Koelle. 2013. T-cell immunity to human alphaherpesviruses. Curr. Opin. Virol. 3: 452-460.
57. Cole, D. K., K. Gallagher, B. Lemercier, C. J. Holland, S. Junaid, J. P. Hindley, K. K. Wynn, E. Gostick, A. K. Sewell, A. M. Gallimore, et al. 2012. Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4+ T-cell repertoire selection. Nat. Commun. 3: 665.
58. Moon, J. J., H. H. Chu, M. Pepper, S. J. McSorley, S. C. Jameson, R. M. Kedl, and M. K. Jenkins. 2007. Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
59. Weaver, J. M., F. A. Chaves, and A. J. Sant. 2009. Abortive activation of CD4 T cell responses during competitive priming in vivo. Proc. Natl. Acad. Sci. USA 106: 8647-8652.
60. Eisfeld, A. J., S. E. Turse, S. A. Jackson, E. C. Lerner, and P. R. Kinchington. 2006. Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase. J. Virol. 80: 1710-1723.
61. Imbalzano, A. N., D. M. Coen, and N. A. DeLuca. 1991. Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene. J. Virol. 65: 565-574.
62. Loret, S., and R. Lippe. 2012. Biochemical analysis of infected cell polypeptide (ICP)0, ICP4, UL7 and UL23 incorporated into extracellular herpes simplex virus type 1 virions. J. Gen. Virol. 93: 624-634.
63. McGeoch, D. J., A. Dolan, S. Donald, and D. H. Brauer. 1986. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res. 14: 1727-1745.
64. Arvin, A. M., M. Sharp, M. Moir, P. R. Kinchington, M. Sadeghi-Zadeh, W. T. Ruyechan, and J. Hay. 2002. Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. Viral Immunol. 15: 507-516.
65. Arvin, A. M., M. Sharp, S. Smith, C. M. Koropchak, P. S. Diaz, P. Kinchington, W. Ruyechan, and J. Hay. 1991. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J. Immunol. 146: 257-264.
66. Jing, L., J. T. Schiffer, T. M. Chong, J. J. Bruckner, D. H. Davies, P. L. Felgner, J. Haas, A. Wald, G. M. Verjans, and D. M. Koelle. 2013. CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence. J. Virol. 87: 2617-2627.
67. Laing, K. J., A. S. Magaret, D. E. Mueller, L. Zhao, C. Johnston, S. C. De Rosa, D. M. Koelle, A. Wald, and L. Corey. 2010. Diversity in CD8+ T cell function and epitope breadth among persons with genital herpes. J. Clin. Immunol. 30: 703-722.
68. Koelle, D. M., S. N. Reymond, H. Chen, W. W. Kwok, C. McClurkan, T. Gyaltsong, E. W. Petersdorf, W. Rotkis, A. R. Talley, and D. A. Harrison. 2000. Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J. Virol. 74: 10930-10938.
69. van Velzen, M., L. Jing, A. D. M. E. Osterhaus, A. Sette, D. M. Koelle, and G. M. G. M. Verjans. 2013. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in human ganglia. PLoS Pathog. 9: e1003547.
70. Wyrwicz, L. S., and L. Rychlewski. 2007. Fold recognition insights into function of herpes ICP4 protein. Acta Biochim. Pol. 54: 551-559.
71. Atherton, S. S., and J. W. Streilein. 2007. Two waves of virus following anterior chamber inoculation of HSV-1. 1987. Ocul. Immunol. Inflamm. 15: 195-204.
72. Vandercam, T., R. Q. Hintzen, J. H. de Boer, and A. Van der Lelij. 2008. Herpetic encephalitis is a risk factor for acute retinal necrosis. Neurology 71: 1268-1274.
73. Barcy, S., and L. Corey. 2001. Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells. J. Immunol. 166: 6242-6249.
74. Temme, S., A. M. Eis-Hubinger, A. D. McLellan, and N. Koch. 2010. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J. Immunol. 184: 236-243.
75. Trgovcich, J., D. Johnson, and B. Roizman. 2002. Cell surface major histocompatibility complex class II proteins are regulated by the products of the g(1) 34.5 and U(L)41 genes of herpes simplex virus 1. J. Virol. 76: 6974-6986.